Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
124.76
Aug 21 • 3:59 PM ET Dollar change+5.61 Percentage change(4.71%)
Aftermarket Close
124.76
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
698.14M
Enterprise Value
828.79M
Income
4.80M
Sales
249.72M
Book/sh
33.73
Cash/sh
5.49
Employees
717
IPO
Feb 29, 1984
P/E
147.61
Forward P/E
14.26
PEG
-
P/S
2.80
P/B
3.70
P/C
22.74
P/FCF
13.20
EV/EBITDA
18.24
EV/Sales
3.32
Quick Ratio
1.32
Current Ratio
1.79
Debt/Eq
0.85
LT Debt/Eq
0.81
Option/Short
No / Yes
EPS (ttm)
0.85
EPS next Y
8.75
EPS next Q
1.59
EPS this Y
-33.54%
EPS next Y
15.34%
EPS next 5Y
-
EPS past 3/5Y
90.85% 13.55%
Sales past 3/5Y
4.38% 13.22%
EPS Y/Y TTM
842.96%
Sales Y/Y TTM
3.04%
EPS Q/Q
-42.44%
Sales Q/Q
1.00%
Insider Own
4.24%
Insider Trans
-0.53%
Inst Own
90.30%
Inst Trans
0.04%
ROA
1.12%
ROE
2.66%
ROIC
1.40%
Gross Margin
57.35%
Oper. Margin
9.00%
Profit Margin
1.92%
SMA20
16.80%
SMA50
22.65%
SMA200
35.63%
Trades
Shs Outstand
5.60M
Shs Float
5.36M
52W High
121.90 2.35%
52W Low
58.83 112.06%
Volatility
5.86% 5.46%
ATR (14)
5.90
RSI (14)
71.83
Beta
0.95
Rel Volume
0.79
Avg Volume
203.38K
Volume
160,693
Perf Week
17.65%
Perf Month
23.59%
Perf Quarter
14.34%
Perf Half Y
33.63%
Perf YTD
58.93%
Perf Year
86.46%
Perf 3Y
-9.08%
Perf 5Y
-53.60%
Perf 10Y
19.44%
Prev Close
119.15
Price
124.76
Change %
4.71%
Date Action Analyst Rating Change Price Target Change
Aug-07-25Upgrade Wells Fargo Underweight → Equal Weight $67
Aug-28-24Initiated Wells Fargo Underweight $120
Jan-04-24Upgrade Evercore ISI In-line → Outperform $100 → $125
Jan-04-21Downgrade Evercore ISI Outperform → In-line $300
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $287
Oct-02-20Initiated JP Morgan Neutral $260
Dec-04-19Initiated Jefferies Buy
Aug-26-19Initiated Evercore ISI Outperform $250
Jun-10-16Downgrade Sidoti Buy → Neutral
Aug-11-26 08:30AM
01:04AM
Aug-10-26 04:17PM
04:01PM
Aug-03-26 08:00AM
09:50AM Loading…
Jul-06-26 09:50AM
Jun-17-26 04:42AM
May-27-26 08:18AM
08:00AM
May-05-26 01:39PM
Apr-02-26 06:00PM
Mar-09-26 04:30PM
Feb-20-26 07:02AM
Feb-03-26 08:11AM
08:00AM
05:00PM Loading…
Jan-07-26 05:00PM
Dec-18-25 07:00PM
Dec-03-25 05:35PM
Nov-25-25 08:09AM
Nov-12-25 03:14PM
Nov-06-25 07:01PM
04:15PM
Oct-03-25 11:46AM
11:01AM
Sep-22-25 06:53AM
Sep-05-25 06:34PM
Aug-18-25 02:01PM
Aug-05-25 09:15AM
08:10AM
08:00AM
05:45PM Loading…
Jul-31-25 05:45PM
Jul-03-25 12:00PM
Jul-02-25 03:20PM
May-28-25 09:15AM
08:23AM
08:00AM
May-15-25 05:25PM
May-14-25 05:45PM
May-13-25 05:35PM
May-08-25 08:45AM
Apr-07-25 03:00PM
Apr-03-25 03:51PM
Mar-26-25 12:00PM
Feb-13-25 08:31AM
Feb-11-25 12:20PM
Feb-04-25 09:15AM
08:17AM
08:00AM
Jan-17-25 01:15PM
Jan-06-25 03:00PM
Nov-07-24 09:20AM
08:27AM
08:00AM
Oct-15-24 05:02PM
Oct-02-24 02:00PM
Aug-26-24 12:20PM
12:00PM
Aug-16-24 07:51AM
Aug-05-24 08:15AM
08:00AM
Jul-31-24 09:14AM
Jul-08-24 02:00PM
Jun-05-24 11:53AM
06:38AM
06:21AM
06:00AM
May-31-24 06:00AM
May-22-24 06:00AM
Apr-08-24 08:00AM
Apr-04-24 06:24PM
Apr-01-24 10:27AM
Mar-15-24 07:00AM
Feb-19-24 10:23AM
Feb-05-24 09:20AM
08:36AM
08:22AM
08:00AM
Jan-08-24 08:00AM
Jan-04-24 03:00PM
Jan-03-24 08:00AM
Dec-14-23 10:47AM
Nov-06-23 09:10AM
08:13AM
08:00AM
Oct-16-23 03:00AM
Oct-03-23 08:00AM
Sep-22-23 08:09AM
06:20AM
Sep-15-23 01:10AM
Sep-13-23 01:37PM
Sep-11-23 11:21AM
Aug-24-23 04:02PM
Aug-10-23 01:32AM
Aug-03-23 09:35AM
08:27AM
08:00AM
Jul-31-23 07:50AM
Jul-05-23 03:00PM
Jun-21-23 08:00PM
11:50AM
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
VP & CFOMr. John V. Sakys CPA
Senior Vice President of Operations & Continuous ImprovementMr. Brian David Archbold
M.S.Dr. Siddhartha Chandrakant Kadia B.E.
Chief Accounting OfficerMs. Lyndsey Crennen
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Owens Gary MFormer OfficerAug 21 '26Proposed Sale122.5020,0002,450,059Aug 21 03:53 PM
Capone Mark ChristopherDirectorAug 15 '26Option Exercise0.002,78406,213Aug 17 07:40 PM
Alltoft Jennifer SadieDirectorAug 15 '26Option Exercise0.002,78407,662Aug 17 07:32 PM
Ladiwala Shiraz ShabanaliDirectorAug 15 '26Option Exercise0.003,810012,333Aug 17 05:55 PM
Hall ShannonDirectorAug 15 '26Option Exercise0.002,78406,973Aug 17 05:46 PM
Tripeny R TonyDirectorAug 15 '26Option Exercise0.002,78409,082Aug 17 05:30 PM
Sullivan John JamesDirectorAug 15 '26Option Exercise0.002,784020,618Aug 17 05:01 PM
Sullivan John JamesDirectorAug 13 '26Sale112.807,093800,09017,834Aug 17 12:18 PM
Kadia SiddharthaPresident and CEOAug 13 '26Buy112.807,093800,0907,093Aug 17 11:49 AM
Tripeny R TonyDirectorAug 13 '26Buy113.69900102,3216,298Aug 17 11:27 AM
Crennen Lyndsey ElizabethCAOJun 18 '26Option Exercise95.1072669,0432,199Jun 23 01:34 PM
Crennen Lyndsey ElizabethCAOJun 22 '26Sale89.5044239,5602,020Jun 23 01:34 PM
Archbold Brian DavidSVP OperationsJun 18 '26Option Exercise95.103,324316,1127,034Jun 23 01:02 PM
Archbold Brian DavidSVP OperationsJun 22 '26Sale89.502,516225,1876,377Jun 23 01:02 PM
Sakys JohnCFOJun 18 '26Option Exercise95.103,792360,61920,330Jun 23 12:23 PM
Sakys JohnCFOJun 22 '26Sale89.502,827253,02219,785Jun 23 12:23 PM
Sakys JohnOfficerJun 22 '26Proposed Sale89.502,827253,022Jun 22 03:56 PM
Archbold Brian DavidOfficerJun 22 '26Proposed Sale89.502,516225,187Jun 22 03:51 PM
Archbold Brian DavidSVP OperationsJun 16 '26Sale101.271,151116,5583,710Jun 17 12:23 PM
Crennen Lyndsey ElizabethCAOJun 16 '26Sale101.2711811,9501,473Jun 17 12:19 PM
Sakys JohnCFOJun 16 '26Sale101.271,223123,85016,538Jun 17 12:09 PM
Archbold Brian DavidOfficerJun 16 '26Proposed Sale101.271,151116,558Jun 16 03:33 PM
Sakys JohnOfficerJun 16 '26Proposed Sale101.271,223123,850Jun 16 03:31 PM
Owens Gary MFormer OfficerJun 16 '26Proposed Sale101.273,706375,296Jun 16 03:29 PM
Archbold Brian DavidSVP OperationsJun 15 '26Option Exercise104.082,454255,4124,861Jun 16 02:44 PM
Sakys JohnCFOJun 15 '26Option Exercise104.082,717282,78517,761Jun 16 02:15 PM
Ladiwala Shiraz ShabanaliDirectorMar 10 '26Buy72.233,500252,8058,523Mar 10 05:43 PM
Capone Mark ChristopherDirectorMar 10 '26Buy76.351,30199,3313,429Mar 10 03:46 PM
Tripeny R TonyDirectorMar 10 '26Buy76.001,31599,9405,398Mar 10 03:39 PM
Owens Gary MPresident and CEOOct 27 '25Option Exercise0.0011,558064,135Oct 28 03:08 PM
Last Close
22.50
Aug 21 • 3:59 PM ET Dollar change+1.86 Percentage change(9.04%)
Aftermarket Close
22.70
Aftermarket • 7:53 PM ET Dollar change+0.20 Percentage change(0.89%)
IPX IperionX Ltd ADR daily Stock Chart
Index
-
Market Cap
814.95M
Enterprise Value
753.58M
Income
-53.95M
Sales
0.00M
Book/sh
3.22
Cash/sh
1.82
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
Jun 21, 2022
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
6.99
P/C
12.38
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
4.00
Current Ratio
4.03
Debt/Eq
0.04
LT Debt/Eq
0.03
Option/Short
Yes / Yes
EPS (ttm)
-1.63
EPS next Y
-0.41
EPS next Q
-0.45
EPS this Y
-1313.70%
EPS next Y
76.06%
EPS next 5Y
-
EPS past 3/5Y
9.31% -49.42%
Sales past 3/5Y
- -
EPS Y/Y TTM
-48.46%
Sales Y/Y TTM
-
EPS Q/Q
-73.26%
Sales Q/Q
-
Insider Own
-
Insider Trans
-
Inst Own
14.19%
Inst Trans
30.51%
ROA
-44.04%
ROE
-50.48%
ROIC
-48.36%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-2.25%
SMA50
-11.97%
SMA200
-35.44%
Trades
Shs Outstand
36.22M
Shs Float
33.93M
52W High
61.45 -63.38%
52W Low
20.05 12.22%
Volatility
5.74% 5.63%
ATR (14)
1.56
RSI (14)
44.96
Beta
1.66
Rel Volume
0.97
Avg Volume
288.01K
Volume
279,350
Perf Week
-4.54%
Perf Month
2.55%
Perf Quarter
-37.76%
Perf Half Y
-46.72%
Perf YTD
-37.82%
Perf Year
-45.78%
Perf 3Y
200.00%
Perf 5Y
-
Perf 10Y
-
Prev Close
20.64
Price
22.50
Change %
9.04%
Date Action Analyst Rating Change Price Target Change
Mar-27-26Initiated BTIG Research Buy $40
Jan-13-26Initiated William Blair Outperform
Aug-20-25Initiated Roth Capital Buy $64
Oct-10-24Initiated B. Riley Securities Buy $30
Aug-03-26 08:30AM
Jul-31-26 08:30AM
Jul-30-26 08:30AM
Jul-07-26 07:51PM
Jul-02-26 08:30AM
08:30AM Loading…
Jul-01-26 08:30AM
Jun-15-26 08:30AM
Jun-10-26 08:30AM
Jun-04-26 08:00AM
Jun-01-26 08:30AM
May-21-26 08:30AM
May-04-26 11:45AM
Apr-27-26 09:00AM
08:30AM
Mar-30-26 09:51AM
08:00AM Loading…
Mar-18-26 08:00AM
Mar-16-26 11:30AM
Mar-13-26 10:50AM
Mar-05-26 12:01AM
Mar-04-26 09:40AM
Feb-27-26 05:00AM
Feb-02-26 09:55AM
08:30AM
Jan-30-26 08:30AM
Jan-27-26 07:57AM
Jan-25-26 06:50PM
Jan-23-26 09:40AM
Jan-22-26 08:30AM
Jan-16-26 08:30AM
Dec-15-25 08:30AM
08:30AM Loading…
Nov-17-25 08:30AM
Oct-30-25 08:30AM
Sep-27-25 08:40AM
Sep-26-25 08:30AM
Sep-09-25 01:02AM
Sep-02-25 08:30AM
Aug-26-25 08:30AM
Aug-07-25 08:30AM
Jul-25-25 09:40AM
Jul-23-25 08:30AM
Jul-14-25 12:54PM
Jun-11-25 08:30AM
Jun-10-25 07:30AM
Jun-05-25 08:30AM
May-05-25 12:50PM
Apr-15-25 08:30AM
Apr-08-25 08:30AM
Apr-01-25 08:30AM
Mar-13-25 08:30AM
Mar-11-25 08:30AM
Feb-18-25 08:30AM
Feb-06-25 08:30AM
Jan-28-25 08:30AM
Nov-26-24 08:30AM
Aug-14-24 08:30AM
Jul-02-24 12:00PM
May-01-24 08:30AM
Apr-26-24 08:30AM
Apr-15-24 08:30AM
Feb-14-24 08:30AM
Jan-16-24 08:30AM
Nov-29-23 09:00AM
Nov-08-23 08:30AM
Nov-01-23 08:30AM
Oct-19-23 08:30AM
Oct-09-23 08:30AM
Oct-02-23 08:30AM
Sep-07-23 08:30AM
Sep-06-23 08:30AM
Aug-28-23 08:30AM
Aug-23-23 08:30AM
Aug-17-23 08:30AM
Aug-15-23 08:30AM
Jul-31-23 08:30AM
Jul-10-23 08:30AM
Jun-15-23 08:00AM
Jun-13-23 08:00AM
Apr-27-23 08:30AM
Apr-26-23 08:30AM
Apr-20-23 08:30AM
Mar-28-23 08:00AM
IperionX Ltd. engages in the development of low carbon titanium for advanced industries, including space, aerospace, electric vehicles and 3D printing. It produces titanium metal powders from titanium scrap at its operational pilot facility in Utah and intends to scale production at a Titanium Demonstration Facility in Virginia. The company was founded by Anastasios Arima and Scott Sparks on May 5, 2017 and is headquartered in Charlotte, NC.
B.E.Mr. Todd William Hannigan B. Eng (Hons)
FounderMr. Anastasios Arima B.Com.
President & Chief Strategy OfficerMr. Toby Edgcumbe Symonds
Co-founder & Chief Operating OfficerMr. W. Scott Sparks
Chief Financial OfficerMs. Marcela Rocha Barbosa De Castro
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wyse BeverlyDirectorJul 15 '26Option Exercise0.87106,09392,301745,868Jul 15 09:23 AM
Arima AnastasiosChief Executive OfficerJul 10 '26Buy3.58138,720497,22812,455,502Jul 13 08:38 AM
Hannigan ToddExecutive ChairmanJul 13 '26Buy3.59300,0001,075,98026,633,334Jul 13 08:16 AM
Hannigan ToddExecutive ChairmanJul 10 '26Buy3.58225,000805,18526,333,334Jul 13 08:16 AM
Arima AnastasiosChief Executive OfficerApr 28 '26Buy4.49110,000493,62512,316,782Apr 30 07:38 AM
Hannigan ToddExecutive ChairmanApr 29 '26Buy4.20260,0001,091,76626,108,334Apr 29 09:51 PM
Hannigan ToddExecutive ChairmanApr 28 '26Buy4.48220,000986,01825,848,334Apr 29 09:51 PM
Symonds Toby EdgcumbePresidentMar 27 '26Buy23.8711,000262,55211,000Mar 30 09:23 AM
Tripeny R TonyDirectorMar 27 '26Buy23.764,18799,4644,187Mar 30 09:08 AM
Hannigan ToddDirectorMar 27 '26Buy3.20225,225720,92325,628,334Mar 30 08:57 AM
Arima AnastasiosChief Executive OfficerMar 27 '26Buy3.74479,8001,793,11012,206,782Mar 30 08:38 AM